What Is SCR7 and How Does It Work?

SCR7 is a rationally designed small-molecule inhibitor that targets DNA Ligase IV, the enzyme responsible for the final ligation step in the non-homologous end joining (NHEJ) DNA repair pathway. When a double-strand break (DSB) occurs in genomic DNA, cells can repair it via two major pathways: NHEJ, which is error-prone and dominant in most cell cycle phases, or homology-directed repair (HDR), which is precise but less frequent.

By blocking DNA Ligase IV activity, SCR7 suppresses NHEJ and shifts the balance of DSB repair toward HDR. This property makes SCR7 highly valuable in CRISPR/Cas9 genome editing workflows, where precise, template-driven insertion or correction is desired. Researchers incorporate SCR7 into editing protocols to increase the ratio of HDR outcomes relative to indel-generating NHEJ events.

Key Applications in Research

SCR7 is primarily used as a pharmacological tool to enhance HDR frequency in CRISPR/Cas9-based genome editing across a wide range of cell types and model organisms. Specific applications include:

• Precise gene knock-in: Improving integration of donor templates at Cas9-induced DSB sites.
• Point mutation correction: Facilitating single-nucleotide editing using short single-stranded oligodeoxynucleotide (ssODN) donors.
• Cell line engineering: Generation of isogenic cell lines carrying specific genetic modifications for functional studies.
• In vivo genome editing: Used in some animal model studies to improve the efficiency of HDR-based corrections, though delivery and in vivo pharmacokinetics require careful optimization.

SCR7 is typically added to cell culture medium or co-delivered with CRISPR components. Optimal concentrations and treatment windows should be empirically determined for each experimental system, as effects can vary by cell type and editing context.

Handling, Storage and Solubility

Proper handling and storage of SCR7 are essential to maintain compound integrity and experimental reproducibility. General best-practice guidelines include:

• Storage: Store as supplied at -20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles by preparing single-use aliquots.
• Solubility: SCR7 is typically soluble in DMSO. Prepare concentrated stock solutions in DMSO and dilute into aqueous buffers or culture media immediately before use. Final DMSO concentration in assays should be kept at ≤0.1% to minimize cytotoxicity, though this should be verified for each cell type.
• Stock solution preparation: Vortex and briefly centrifuge the vial before opening. Confirm complete dissolution before use.
• Working concentrations: Specific working concentrations are not stated in the supplied product information; consult peer-reviewed literature and optimize empirically.

Always refer to the Safety Data Sheet (SDS) provided with the product for complete hazard information and disposal instructions.

Quality, Purity and Regulatory Considerations

Aladdin Scientific supplies SCR7 (SKU: S649471) as a research-grade reagent. Key quality considerations include:

• Purity: Specific purity grade and analytical data (e.g., HPLC, NMR) are available on the product page or Certificate of Analysis (CoA). Researchers should request the CoA for lot-specific data to ensure suitability for their application.
• Research use only: SCR7 is supplied strictly for in vitro and in vivo research purposes. It is not approved for human therapeutic use, clinical diagnostics, or veterinary applications.
• Regulatory status: As a research chemical, SCR7 is not subject to pharmaceutical GMP requirements; however, users should comply with all applicable institutional biosafety, chemical hygiene, and waste disposal regulations.